Cyclophosphamide-responsive Lgi1-related limbic encephalitis with basal ganglia hypermetabolism

Acta Neurol Belg. 2016 Sep;116(3):379-81. doi: 10.1007/s13760-015-0567-0. Epub 2015 Nov 21.

Authors

Dimitri Renard¹, Laurent Collombier², Anais Lippi³, Jerome Honnorat⁴, Eric Thouvenot³

Affiliations

¹ Department of Neurology, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, 30029, Nîmes Cedex 4, France. dimitrirenard@hotmail.com.
² Department of Nuclear Medicine, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, 30029, Nîmes Cedex 4, France.
³ Department of Neurology, CHU Nîmes, Hôpital Caremeau, Place du Pr Debré, 30029, Nîmes Cedex 4, France.
⁴ Service de Neuro-oncologie, Hôpital Neurologique, 59 Boulevard Pinel, 69677, Bron, France.

PMID: 26590598
DOI: 10.1007/s13760-015-0567-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Autoantibodies / immunology
Autoantigens / immunology
Autoimmune Diseases / drug therapy
Autoimmune Diseases / immunology
Autoimmune Diseases / metabolism
Basal Ganglia / metabolism*
Cyclophosphamide / therapeutic use*
Humans
Immunosuppressive Agents / therapeutic use*
Intracellular Signaling Peptides and Proteins
Limbic Encephalitis / drug therapy*
Limbic Encephalitis / immunology
Limbic Encephalitis / metabolism
Male
Proteins / immunology*

Substances

Autoantibodies
Autoantigens
Immunosuppressive Agents
Intracellular Signaling Peptides and Proteins
LGI1 protein, human
Proteins
Cyclophosphamide